.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Boehringer Ingelheim
Medtronic
AstraZeneca
McKinsey
Deloitte
Fish and Richardson
Moodys
Cipla
Federal Trade Commission

Generated: June 27, 2017

DrugPatentWatch Database Preview

Minocycline hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for minocycline hydrochloride and what is the scope of minocycline hydrochloride freedom to operate?

Minocycline hydrochloride
is the generic ingredient in seven branded drugs marketed by Impax Labs, Medicis, Zydus Worldwide, Mylan Pharms Inc, Triax Pharms, Sun Pharm Inds, Sun Pharm Inds Ltd, Sandoz, Impax Labs Inc, Lupin Ltd, Par Pharm, Dr Reddys Labs Ltd, Lederle, Rempex Pharms Inc, Precision Dermat, Alkem Labs Ltd, Torrent Pharma Inc, Aurobindo Pharma Ltd, Watson Labs, Cnty Line Pharms, Sun Pharm Inds Inc, Aurobindo Pharma, Watson Labs Teva, Orapharma, Barr Labs Inc, and Sidmak Labs India, and is included in thirty-three NDAs. There are fourteen patents protecting this compound and four Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Minocycline hydrochloride has forty-six patent family members in twenty-four countries.

There are thirteen drug master file entries for minocycline hydrochloride. Forty-eight suppliers are listed for this compound. There are seven tentative approvals for this compound.

Summary for Generic Name: minocycline hydrochloride

Tradenames:7
Patents:14
Applicants:26
NDAs:33
Drug Master File Entries: see list13
Suppliers / Packagers: see list48
Bulk Api Vendors: see list45
Clinical Trials: see list2,402
Patent Applications: see list2,387
Therapeutic Class:Dental and Oral Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:minocycline hydrochloride at DailyMed

Pharmacology for Ingredient: minocycline hydrochloride

Ingredient-typeTetracyclines
Drug ClassTetracycline-class Drug

Tentative approvals for MINOCYCLINE HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
► Subscribe► SubscribeEQ 45MG BASETABLET, EXTENDED RELEASE;ORAL
► Subscribe► SubscribeEQ 135MG BASETABLET, EXTENDED RELEASE;ORAL
► Subscribe► SubscribeEQ 115MG BASETABLET, EXTENDED RELEASE;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs
MINOCYCLINE HYDROCHLORIDE
minocycline hydrochloride
CAPSULE;ORAL065005-003Apr 18, 2001ABRXNoNo► Subscribe► Subscribe
Sidmak Labs India
MINOCYCLINE HYDROCHLORIDE
minocycline hydrochloride
TABLET, EXTENDED RELEASE;ORAL204394-005Dec 30, 2015ABRXNoNo► Subscribe► Subscribe
Lupin Ltd
MINOCYCLINE HYDROCHLORIDE
minocycline hydrochloride
TABLET, EXTENDED RELEASE;ORAL091424-004Nov 30, 2011ABRXNoNo► Subscribe► Subscribe
Sun Pharm Inds Ltd
XIMINO
minocycline hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL201922-005Jul 11, 2012RXNoNo7,544,373► SubscribeY ► Subscribe
Cnty Line Pharms
DYNACIN
minocycline hydrochloride
CAPSULE;ORAL063067-002Sep 15, 1999ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: minocycline hydrochloride

Country Document Number Estimated Expiration
Australia2003223384► Subscribe
Australia2011252919► Subscribe
China101208097► Subscribe
European Patent Office2263596► Subscribe
Singapore185513► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Chinese Patent Office
McKesson
US Department of Justice
Boehringer Ingelheim
Julphar
Cerilliant
QuintilesIMS
Cantor Fitzgerald
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot